Meu SciELO
Serviços Personalizados
Journal
Artigo
Indicadores
Citado por SciELO
Acessos
Links relacionados
Citado por Google
Similares em SciELO
Similares em Google
Compartilhar
Anales de Medicina Interna
versão impressa ISSN 0212-7199
Resumo
BONILLA HERNAN, Mª G.; COBO IBANEZ, T.; MIGUEL MENDIETA, E. de e MARTIN-MOLA, E.. Infliximab (anti-TNF alfa) in the treatment of adult Still’s disease: Two cases. An. Med. Interna (Madrid) [online]. 2004, vol.21, n.1, pp.23-26. ISSN 0212-7199.
Adult Still´s disease is a systemic inflammatory disorder of unknown etiolgy. First-line treatment for Still´s disease includes nonsteroidal anti-inflammatory drugs and corticosteroids. In refractory cases o when the dose of corticosteroid is unacceptbly high, other disease modifiying antirheumatic drugs have been used. But recent study showed the efficacy anti-TNF therapy in adult Sill´s disease refractory to conventional therapy We report a favourable response to infliximab in two patients who has proved resistant to conventional therapy.
Palavras-chave : Adult Still´s disease; Infliximab; Anti-TNF-a treatment.